4.5 Article

Protein 4.1G binds to a unique motif within the Fc-gamma RI cytoplasmic tail

Journal

MOLECULAR IMMUNOLOGY
Volume 45, Issue 7, Pages 2069-2075

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2007.10.024

Keywords

Fc receptor; yeast two-hybrid; molecular interaction; mutagenesis; domain mapping

Ask authors/readers for more resources

The C-terminal domain of protein 4.1G was identified to interact with the cytosolic tail of the high affinity IgG receptor, Fc gamma RI, in yeast two-hybrid screens. Proteins of the 4.1 family have previously been found to mediate receptor/cytoskeleton interactions. In the study presented here, we show an alternatively spliced 4.1G product to be associated with increased Fc-gamma RI binding in yeast two-hybrid assays, and to be selectively enriched in most immune cells at the transcript level. In addition, a detailed analysis of the 4.1G 'docking site' within Fc gamma RI is provided by examining Fc gamma RI-CY-truncated and alanine-substituted mutants. These pointed to an Fc gamma RI membrane-proximal core motif of HxxBxxxBB (H represents hydrophobic residues, B basic residues and x represents any residue), followed by hydrophobic and (potentially) negatively charged residues to be central for interaction with protein 4.1G. (C) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Respiratory System

Intestinal organoids for Cystic Fibrosis research

E. de Poel, J. W. Lefferts, J. M. Beekman

JOURNAL OF CYSTIC FIBROSIS (2020)

Article Respiratory System

R117H-CFTR function and response to VX-770 correlate with mRNA and protein expression in intestinal organoids

Peter Van Mourik, Paul van Haaren, Evelien Kruisselbrink, Cemil Korkmaz, Hettie M. Janssens, Karin M. de Winter-de Groot, Cornelis K. van der Ent, Marne C. Hagemeijer, Jeffrey M. Beekman

JOURNAL OF CYSTIC FIBROSIS (2020)

Article Allergy

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Inge Van de Walle, Karen Silence, Kevin Budding, Liesbeth Van de Ven, Kim Dijkxhoorn, Elisabeth de Zeeuw, Cafer Yildiz, Sofie Gabriels, Jean-Michel Percier, Johanna Wildemann, Jan Meeldijk, Peter J. Simons, Louis Boon, Linda Cox, Rob Holgate, Rolf Urbanus, Henny G. Otten, Jeanette H. W. Leusen, Christophe Blanchetot, Hans de Haard, C. Erik Hack, Peter Boross

Summary: ARGX-117 is a promising new complement inhibitor that uniquely targets both the classical and lectin pathways by binding to the Sushi-2 domain of C2. It prevents complement-mediated cytotoxicity in in vitro models for autoimmune hemolytic anemia and antibody-mediated rejection of organ transplants.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Oncology

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions

Niklas Baumann, Thies Roesner, J. H. Marco Jansen, Chilam Chan, Klara Marie Eichholz, Katja Klausz, Dorothee Winterberg, Kristina Mueller, Andreas Humpe, Renate Burger, Matthias Peipp, Denis M. Schewe, Christian Kellner, Jeanette H. W. Leusen, Thomas Valerius

Summary: The study shows that inhibiting glutaminyl cyclase can enhance the immunotherapeutic effects on tumor cells. Inhibition of glutaminyl cyclase reduces the specific signal of CD47 at the SIRP alpha binding site, leading to increased efficiency of tumor cell phagocytosis and ADCC reactions mediated by antibodies.

CANCER SCIENCE (2021)

Article Infectious Diseases

Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort

Arthur H. van Stigt, Katrien Oude Rengerink, Kitty W. M. Bloemenkamp, Wouter de Waal, Sabine M. P. J. Prevaes, Thuy-My Le, Femke van Wijk, Maaike Nederend, Anneke H. Hellinga, Christianne S. Lammers, Gerco den Hartog, Martijn J. C. van Herwijnen, Johan Garssen, Leon M. J. Knippels, Lilly M. Verhagen, Caroline G. M. de Theije, Alejandro Lopez-Rincon, Jeanette H. W. Leusen, Belinda Van't Land, Louis Bont

Summary: The PRIMA cohort aims to identify novel functions of components in human milk that are protective against respiratory tract infections and allergic diseases early in life through an observational, prospective, and multi-center birth study. It will provide new insights into immunomodulatory components in human milk by collecting and analyzing human milk samples in relation to clinical data.

BMC INFECTIOUS DISEASES (2022)

Article Oncology

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

Tassilo L. A. Wachsmann, Anne K. Wouters, Dennis F. G. Remst, Renate S. Hagedoorn, Miranda H. Meeuwsen, Eline van Diest, Jeanette Leusen, Jurgen Kuball, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Summary: This study compared the activity of CAR T cells and engineered TCR T cells in targeting CD20 antigen, and found that CAR T cells were more potent in the short term but their expansion was impaired with increased antigen exposure, while eTCR T cells performed better under high antigenic pressure.

ONCOIMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®

Alexander H. Staudacher, Vasilios Liapis, Nicole L. Wittwer, William Tieu, Hiu Chun Lam, Jeanette Leusen, Michael P. Brown

Summary: The interaction between Fc and Fc gamma R is not essential for the diagnostic or therapeutic applications of chDAB4 conjugates, as tumor-associated macrophages mainly respond to endogenous signals rather than functional expression of Fc gamma R during phagocytosis.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Immunology

Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

Chilam Chan, Marta Lustig, Niklas Baumann, Thomas Valerius, Geert van Tetering, Jeanette H. W. Leusen

Summary: The expression of checkpoint molecules by tumor cells hampers the clinical responses to therapeutic antibodies. Myeloid checkpoint inhibition in combination with IgA-based treatment could significantly enhance IgA therapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab

Niklas Baumann, Christian Arndt, Judith Petersen, Marta Lustig, Thies Roesner, Katja Klausz, Christian Kellner, Miriam Bultmann, Lorenz Bastian, Fotini Vogiatzi, Jeanette H. W. Leusen, Renate Burger, Denis M. Schewe, Matthias Peipp, Thomas Valerius

Summary: Antibody-based immunotherapy is increasingly used to treat acute lymphoblastic leukemia (ALL) patients. This study investigates the effects of CD38 antibodies, targeting T-ALL cells expressing CD38, on tumor cell killing through antibody-dependent cellular phagocytosis (ADCP) and antibody-dependent cell-mediated cytotoxicity (ADCC). The study shows that IgA2 variants of CD38 antibodies are more effective in killing tumor cells through myeloid cells. The interactions between CD47 and SIRP alpha negatively regulate ADCP and ADCC. Additionally, treatment with all-trans retinoic acid (ATRA) enhances CD38 expression and further enhances ADCP and ADCC.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

IgG Subclass-Dependent Pulmonary Antigen Retention during Acute IgG-Dependent in Mice

Biliana Todorova, Ophelie Godon, Eva Conde, Caitlin M. Gillis, Bruno Iannascoli, Odile Richard-Le Goff, Daniel Fiole, Lubka T. Roumenina, Jeanette H. W. Leusen, Andrew J. Murphy, Lynn E. Macdonald, Laurent L. Reber, Friederike Joensson, Pierre Bruhns

Summary: In mouse models of active systemic anaphylaxis, IgG-allergen immune complexes predominantly accumulate in the lungs. The accumulation of allergens in the lungs does not rely on IgG receptors, complement component C1q, neutrophils, or macrophages. Neutrophils and monocytes recruited to the lungs capture high amounts of allergens, leading to downregulation of surface IgG receptors and activation.

JOURNAL OF IMMUNOLOGY (2022)

Correction Immunology

Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies? (vol 13, 932155, 2022)

Chilam Chan, Marta Lustig, Niklas Baumann, Thomas Valerius, Geert Van Tetering, Jeanette H. W. Leusen

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses

Firas Hamdan, Michaela Feodoroff, Salvatore Russo, Manlio Fusciello, Sara Feola, Jacopo Chiaro, Gabriella Antignani, Francesca Greco, Jeanette Leusen, Erkko Ylosmaki, Mikaela Gronholm, Vincenzo Cerullo

Summary: Immune checkpoint inhibitors have shown clinical success in cancer treatment, but there is room for improvement. Researchers have developed an oncolytic adenovirus, Ad-Cab, to enhance the efficacy of PD-L1 checkpoint inhibitors. By adding somatic mutations to increase natural killer (NK) cell activation, they further improved the effectiveness of the therapy. The modified adenovirus demonstrated targeted release in the tumor microenvironment and better tumor killing.

MOLECULAR THERAPY-ONCOLYTICS (2023)

Article Oncology

Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains

Marjolein C. Stip, J. H. Marco Jansen, Maaike Nederend, Maria Tsioumpekou, Mitchell Evers, Patricia A. Olofsen, Friederike Meyer-Wentrup, Jeanette H. W. Leusen

Summary: The transgenic mouse model expressing human Fc alpha RI is a valuable tool for studying the efficacy of IgA immunotherapy against infectious diseases and cancer.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Review Cell Biology

The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease

Maria Tsioumpekou, Danielle Krijgsman, Jeanette H. W. Leusen, Patricia A. Olofsen

Summary: Neutrophils are important immune cells that make up 50-70% of the white blood cell population. In infection and cancer, neutrophil numbers increase due to the secretion of various substances by cells present in the inflamed tissue or tumor microenvironment. The function of neutrophils in cancer has gained attention, as they can have both pro-tumor and anti-tumor effects, depending on the cytokine environment in the tumor microenvironment.

CELLS (2023)

Article Medicine, Research & Experimental

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo

Simone Mester, Mitchell Evers, Saskia Meyer, Jeannette Nilsen, Victor Greiff, Inger Sandlie, Jeanette Leusen, Jan Terje Andersen

Summary: In this study, it was demonstrated that ABD-fused IgA1 binds human FcRn pH-dependently and is rescued from cellular degradation in a receptor-specific manner in the presence of albumin. Furthermore, the presence of ABD led to an extended half-life of IgA1 in human FcRn transgenic mice, with the light chain fusion showing the longest half-life. The study suggests that an ABD, which does not interfere with albumin binding to human FcRn, may be used to extend the half-life of IgA.
No Data Available